Polymer Capital Management (Hk) LTD Legend Biotech Corp Call Options Transaction History
Polymer Capital Management (Hk) LTD
- $494 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LEGN
# of Institutions
198Shares Held
74.2MCall Options Held
374KPut Options Held
387K-
Price T Rowe Associates Inc Baltimore, MD11.5MShares$588 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$384 Million5.01% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$340 Million7.6% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$293 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.77MShares$244 Million1.06% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $8.57B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...